Prostate Cancer - Results from #120

Prostate cancer screening-stepping forward with MRI. May 10, 2023

Focal Cryoablation of the Prostate: Primary Treatment in 163 Patients With Localized Prostate Cancer. May 10, 2023

Applying Quality Indicators to Examine Quality of Care During Active Surveillance in Low-Risk Prostate Cancer: A Population-Based Study. May 10, 2023

Treatment-related toxicity using prostate bed versus prostate bed and pelvic lymph node radiation therapy following radical prostatectomy: A national population-based study. May 9, 2023

Effect of type of definitive treatment on race-based differences in prostate cancer-specific survival. May 9, 2023

Combination therapy for high-volume versus low-volume metastatic hormone-sensitive prostate cancer: A systematic review and network meta-analysis. May 9, 2023

The 17-Gene Genomic Prostate Score Assay Is Prognostic for Biochemical Failure in Men With Localized Prostate Cancer After Radiation Therapy at a Community Cancer Center. May 9, 2023

The new era of prostate-specific membrane antigen-directed immunotherapies and beyond in advanced prostate cancer: a review. May 9, 2023

Salvage radiotherapy after radical prostatectomy: analysis of toxicity by dose-fractionation in the RADICALS-RT trial. May 9, 2023

Dose-Escalated Radiotherapy Alone or in Combination With Short-Term Androgen Deprivation for Intermediate-Risk Prostate Cancer: Results of a Phase III Multi-Institutional Trial. May 9, 2023

Radium-223 Utilization Patterns and Outcomes in Clinical Practice. May 8, 2023

15-year biochemical failure, metastasis, salvage therapy, and cancer-specific and overall survival rates in men treated with robotic radical prostatectomy for PSA-screen detected prostate cancer. May 8, 2023

67Ga-PSMA I&T for Radioguided Surgery of Lymph Node Metastases in Patients With Biochemical Recurrence of Prostate Cancer. May 8, 2023

Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol. May 8, 2023

Impact of Zone of Origin in Anterior Dominant Prostate Cancer: Long-Term Biochemical Recurrence-Free Survival in an Anatomically Well-Characterized Cohort. May 8, 2023

First-in-patient study of OTL78 for intraoperative fluorescence imaging of prostate-specific membrane antigen-positive prostate cancer: a single-arm, phase 2a, feasibility trial. May 8, 2023

Racial Disparity in Outcomes Among Prostate Cancer Patients in the Post-Affordable Care Act Period. May 8, 2023

Influence of neighborhood social and natural environment on prostate tumor histology in a cohort of male health professionals. May 5, 2023

Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate Cancer. May 5, 2023

Flutamide With or Without PROSTVAC in Non-metastatic Castration Resistant (M0) Prostate Cancer. May 5, 2023

Page 7 of 1305